• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.

作者信息

Eichhorst Barbara, Ghia Paolo

机构信息

Department I Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Germany.

Strategic Research Program on CLL, Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy.

出版信息

Hemasphere. 2020 Dec 29;5(1):e520. doi: 10.1097/HS9.0000000000000520. eCollection 2021 Jan.

DOI:10.1097/HS9.0000000000000520
PMID:33403356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7773331/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2baa/7773331/322c577fe6d3/hs9-5-e520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2baa/7773331/322c577fe6d3/hs9-5-e520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2baa/7773331/322c577fe6d3/hs9-5-e520-g001.jpg

相似文献

1
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up of Chronic Lymphocytic Leukemia.欧洲血液学协会认可欧洲肿瘤内科学会关于慢性淋巴细胞白血病诊断、治疗及随访的临床实践指南。
Hemasphere. 2020 Dec 29;5(1):e520. doi: 10.1097/HS9.0000000000000520. eCollection 2021 Jan.
2
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Myelodysplastic Syndromes.欧洲血液学协会认可欧洲肿瘤内科学会关于骨髓增生异常综合征诊断、治疗及随访的临床实践指南。
Hemasphere. 2022 Feb 24;6(3):e695. doi: 10.1097/HS9.0000000000000695. eCollection 2022 Mar.
3
EHA Endorsement of ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up for Waldenström's Macroglobulinemia.欧洲血液学年会认可欧洲肿瘤内科学会关于华氏巨球蛋白血症诊断、治疗及随访的临床实践指南。
Hemasphere. 2021 Sep 10;5(10):e634. doi: 10.1097/HS9.0000000000000634. eCollection 2021 Oct.
4
EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas.欧洲血液学协会（EHA）对欧洲肿瘤内科学会（ESMO）边缘区淋巴瘤临床实践指南的认可。
Hemasphere. 2020 Mar 11;4(2):e351. doi: 10.1097/HS9.0000000000000351. eCollection 2020 Apr.
5
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Follicular Lymphoma.欧洲血液学协会（EHA）认可欧洲医学肿瘤学会（ESMO）关于新诊断和复发滤泡性淋巴瘤的临床实践指南。
Hemasphere. 2021 Apr 21;5(5):e559. doi: 10.1097/HS9.0000000000000559. eCollection 2021 May.
6
EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma.欧洲血液学协会（EHA）认可欧洲肿瘤内科学会（ESMO）关于新诊断和复发套细胞淋巴瘤的临床实践指南。
Hemasphere. 2020 Aug 17;4(5):e464. doi: 10.1097/HS9.0000000000000464. eCollection 2020 Oct.
7
Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi50-4. doi: 10.1093/annonc/mdr377.
8
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.
9
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤：欧洲血液学协会-欧洲肿瘤内科学会诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3.
10
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.多发性骨髓瘤：欧洲血液学协会-欧洲肿瘤内科学会诊断、治疗及随访临床实践指南
Hemasphere. 2021 Feb 3;5(2):e528. doi: 10.1097/HS9.0000000000000528. eCollection 2021 Feb.

引用本文的文献

1
Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States.影响复发/难治性慢性淋巴细胞白血病和套细胞淋巴瘤治疗决策的知识、技能和信心差距：法国、德国和美国的定量调查研究。
BMC Cancer. 2024 Aug 13;24(1):1003. doi: 10.1186/s12885-024-12745-1.
2
There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemia.老狗也有活力：华氏巨球蛋白血症的免疫化学疗法。
Leukemia. 2024 Jun;38(6):1435-1436. doi: 10.1038/s41375-024-02195-w. Epub 2024 Mar 7.
3

本文引用的文献

1
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Jan;32(1):23-33. doi: 10.1016/j.annonc.2020.09.019. Epub 2020 Oct 19.
2
From Biology to Therapy: The CLL Success Story.从生物学到治疗：慢性淋巴细胞白血病的成功故事
Hemasphere. 2019 Feb 9;3(2):e175. doi: 10.1097/HS9.0000000000000175. eCollection 2019 Apr.
3
Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union.
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency.
接受一线伊布替尼治疗的慢性淋巴细胞白血病伴 TP53 异常患者的结局：来自意大利药品管理局的全国注册研究。
Blood Cancer J. 2023 Jun 28;13(1):99. doi: 10.1038/s41408-023-00865-z.
4
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia.苯达莫司汀在老年淋巴瘤患者中的实际应用
J Pers Med. 2021 Mar 30;11(4):249. doi: 10.3390/jpm11040249.
欧盟罕见病认定程序中血液系统恶性肿瘤的流行趋势变化
Orphanet J Rare Dis. 2017 Jan 21;12(1):17. doi: 10.1186/s13023-017-0567-7.